Ke lāʻau lapaʻau Farmasulin: nā ʻōlelo hoʻohana no ka hoʻohana ʻana

ʻO Farmasulin® N NP a ʻo Farmasulin® N 30/70 he mākaukau o ka insulin kanaka i loaʻa me ka ʻenehana DNA recombinant. Loaʻa ka hope i nā waiwai a pau o ka insulin. Hoʻokomo pono nā lāʻau lapaʻau i ka hoʻoliʻoliʻenehana kalaiʻa i nā umauma. E hōʻemi i ke kō o ke koko. Hāʻawi lākou i ka hoʻopiʻi ʻana i ka lawe ʻana o nā kao a me nā waikawa amino i loko o ke kikowaena intracellular, ke hoʻomakeʻa ana i ka lipolysis, ka hoʻoulu ʻana i ka synthesis o RNA a me nā protein, me ka hoʻōla ʻana i ka synthly glycogen. Hoʻonui nā lāʻau i ka kahe o ka pāhana i loko o nā pūpuna mai ke wahi pericellular, e kōkua ana i ka hōʻemi o ke kiʻekiʻe o ka depolarization diastolic myocardial e loaʻa ana me ka cardiopathy a me nā hopena ʻaoʻao i ka wā e hoʻohana ai i ka digitalis, GCS a me catecholamines.
ʻO ka hoʻomaka ʻana o ka hopena he 1 hola ma hope o ka hoʻokō ʻana o Farmasulin® N NP a i 30 mau minuke ma hope o ka hoʻokō ʻana o Farmasulin® H 30/70. ʻO ka ʻike kiʻekiʻe kiʻekiʻe a me ka hopena therapeutic e nānā ana ma waena o 2 a 8 mau hola ke hoʻohana nei ʻo Farmasulin® N NP a i ʻole ma waena o 1 a me 8 mau hola i ka wā e hoʻohana ai ʻo Farmasulin® H 30/70. ʻO ka lōʻihi o ka mālama ʻana i ka mālama therapeutic he 18-20 mau hola a i ʻole 14-15 mau hola, kēlā

Nā hōʻailona no ka hoʻohanaʻana i ka lāʻau Farmasulin

ʻO ka diabetes mellitus hilinaʻi i loko o ka maʻi (type I), non-insulin-dependence mellitus (type II), inā ʻaʻole hiki ke loaʻa ka uku ʻana i ka maʻi me kahi meaʻai a me nā lāʻau hypoglycemic waha. ʻO kēlā me kēia ʻano maʻi maʻi paʻakikī e ka maʻi ʻeha, nā maʻi ʻeha o ka mālama ʻia, gangrene, insufficiency cardiovascular me ka congestion, retinopathy holomua, ka hana hoʻokō ʻana i nā maʻi me ka maʻi maʻi, ketoacidosis maʻi maʻi, precoma a me kahi coma, kū'ē i ka sulfonylureas, wā hapai i nā mea maʻi maʻi maʻi.

ʻO ka hoʻohanaʻana i ka lāʻau ʻo Farmasulin

P / c. Hoʻonohonoho ʻia nā ʻoka a me ka manawa o ka hoʻokele ʻana no kēlā me kēia maʻi. Hoʻohana ʻia ka lāʻau lāʻau 1 a i ʻole i pinepine i ka lā. ʻO ka huakaʻi ma waena o ke kahakaha a me nā ʻaʻai ʻai o ka meaʻai ma mua o 45-60 mau minuke (ʻaʻole iʻoi aku ma mua o 30 mau minuke ke hoʻohana ʻia ʻo Farmasulin® N 30/70). ʻO ka hoʻohanaʻana i ka lāʻau pono e hele pū me kahi meaʻai koi. Ke hoʻoholo nei i ka ʻike o ka calorie o ka meaʻai (ma ke ʻano he kānāwai, 1700-3000 kaloli) pono ke alakaʻi i ke kaumaha o ke kino o ka mea maʻi, me ke ʻano o kāna hana. Ke hoʻoholo nei i ka hopena o mua o ka lāʻau lapaʻau, pono ia e alakaʻi e ke kiʻekiʻe o ka wikiwiki i ka glycemia a i ka lā, hele i ka pae o glucosuria i ka lā. I ka ʻike kikoʻī ʻana o nā kūmole o ka lāʻau lapaʻau, hiki ke alakaʻi ʻia i nā noʻonoʻo ʻana penei: inā ʻoi aku ka nui o ka glycemia ma mua o 9 mmol / L, e koi ʻia ana ke kime o ka IU no ka hoʻoponopono ʻana i kēlā me kēia 0.45-00.9 mmol / L o ka glucose o ke koko. Ke lawe nei ka koho hope loa o kahi maʻa i lalo o lalo o ka kaohi o ke kūlana maʻamau o ka mea maʻi a mālama i ka glucosuria a me ka glycemia, i ʻike ʻia i ka wā o ke hoʻohana ʻana i ka lāʻau. ʻO ka maʻamau, ʻo ka nui o kēlā me kēia lā o ka lāʻau ka 0.5-1.0 IU / kg kaupaona kino o nā pākeke a ʻaʻole pono e hoʻonui i ka 0.7 IU / kg momona kino i nā keiki. I nā mea maʻi me ka papa labile o ka maʻi, i ka wā hāpai, i nā keiki - kahi hoʻololi i ke ʻano o ka insulin e ʻaʻole iʻoi aku i ka 2-4 IU i ka 1 mau maʻi.
Wili? Ana
Pono ʻoe e ʻike he hoʻohana ʻia kahi syringe, kahi puka o ka mea e pili ana i ka neʻe o ka insulin i kuhikuhi ʻia. Hoʻohana ʻia kahi syringe o nā ʻano like a me ka hōʻailona. ʻO ka hemahema o ka nānā ʻana i ka wā e hoʻohana ai i kahi syringe hiki ke alakaʻi i ka hewa hewa ʻana o ka insulin. Hoʻopuka ʻia ka ʻōlelo maʻi penei:

Ma mua o ka hōʻiliʻili ʻana i ka insulin mai kahi vial, pono ia e nānā i ke kūlana o kāna mau mea. I ka hihia o ka honu a i ʻole ka nānā ʻana o kahi kala o ka supernatant ma hope o ka hoʻopaʻa ʻana i nā ʻike o ke kō, ʻaʻole pono kēia lāʻau lapaʻau. Ke hele koke nei i ka hoʻonāukiuki ʻana, ua ʻōwili ʻia ka hana hoʻowalewale ma waena o nā pālela i lilo ai ke ʻano o ka haunaele ma loko o ke kīʻaha.
ʻO ke Insulin ka hōʻiliʻili ʻia mai ka pahu kaulike ma ke kui ʻana me ka jarika syringe ʻo kahi ʻokaʻane i hānai ʻia me ka waiʻona a i ʻole ka hopena ʻona o ka iodine. Pono ka wela o ka insulin i ka mahana ma waena o ka lumi.
Inā hoʻokahi wale nō ʻano o ka insulin e hoʻohana ai, a laila:
- huki ʻia ka lewa i ka syringe i kahi waiwai e kūlike me ka nui o ka inika no ka insulin, a ma hope o ka hoʻokuʻu ʻia ʻana o ka ea i loko o ke kīʻaha,
- ua hoʻohuli ʻia ka ʻōlelo kuʻuna a me ke kīʻaha i huli ʻia ke kiʻi a hoʻākoʻi ʻia ka nui o ka insulin.
- ua huki ʻia ka pono mai ka vial. Hoʻokuʻu ʻia ka syringe mai ka lewa a me ka pololei o ka nui o ka nui o ka insulin e nānā.
Inā hui ʻia nā ʻelua o ka insulin, a laila e hoʻokaʻawale i mua o ke kīwī me ka pohō ʻana o ka insulin (turbid solution) e ʻāʻī i waena o nā pālela i lilo ai kona haunaele ma loko o ka nui o ka panina. Kuhi ʻia ka nui o ka lewa i ke syringe e pili ana i ka nui o ka ʻōlelo no ka ʻaina o ka insulin, a ua hoʻopuka ʻia kēia ea ma kahi kīʻaha me ka hana o ka insulin. Hoʻokuʻu i ka pono mai ka pahu. Eia hou, huki ʻia ka lewa i ka syringe i ka waiwai o ke ʻano o ka hopena no ka ʻōnaehana o ka insulin. E hoʻokomo i kēia ea i loko o kahi pahu me ka hopena o ka insulin. Huli ʻia ka ʻōlelo kuʻekuʻe me ke kīʻaha i ʻole e kū i lalo ka vial a hoʻākoakoa ʻia ka nui o ka wai ma ka ʻōnaehana ʻokoʻa. E hoʻoneʻe i ka lewa mai ka ʻāʻāwili a ʻike i ka pololei o ka pau ʻana o ka hoʻonā ʻana o ka insulin. Hoʻohui hou ʻia ka lāʻau pono i ke kīʻaha me ka hoʻokuʻu ʻana o ka insulin a ua hōʻiliʻili ʻia ka nui o ka ʻōlelo i kauoha ʻia. Hoʻokuʻu i ka lewa mai ka ʻāwili a ʻike i ka maʻa pololei. Pono mau e nānā i ka insulin i ka ʻōlelo i hōʻike ʻia. Mālama kēia i ke kāwili pū ʻana o ka hui ʻana i ka syringe. Ma hope koke o ka pau ʻana o nā hana i luna, hana i kahi inikua.
Ke hoʻopaʻa nei i ka ʻili ma waena o nā manamana lima, e kau ai i ka pūpū i loko o ka paʻu i ke kihi ʻo e like me 45 ° a inikini insulin s / c.
Hoʻokuʻu ʻia ka ʻāina nui a hoʻopaʻa ʻia ʻo ka pūnaewele injection no kekahi mau kekona e pale ai i ka kahe o ka insulin.
Pono e hoʻololi i ka pūnaewele injection.

Nā hopena ʻaoʻao o ka lāʻau lapaʻau Pharmasulin

Kekahi - lipodystrophy, kū i ka inika, kūʻai o ka hypersensitivity. Me ka hoʻomehana lōʻihi o ka insulin i nā pūnaewele injection, e nānā ʻia nā ʻāpana o ka atrophy a i ʻole hypertrophy o ka momona momona subcutaneous. Hiki i kēia mau meaʻike ke pale aku e ka hoʻololi pinepine ʻana i ka pūnaewele injection. Inā loaʻa kahi hopena maʻi kūlohelohe ʻē aʻe i nā ʻano like o ka insulin i ka mōʻaukala o ka mea maʻi, ua kuhikuhi ʻia kēia mau lāʻau ma hope o ka loaʻa ʻana o kahi hōʻike ʻano intradermal maikaʻi. I kahi hihia o kahi maʻi alakine, pono e hoʻoneʻe i ka mea maʻi i kekahi ʻano insulin a kuhikuhi i ka hoʻonā anti-alaka i ka maʻi. Ma ka hana e lawelawe ai i kahi kiʻekiʻe loa o ka nui o ka insulin a i ʻole kaʻai ʻana i ka ʻai, a me ka hoʻoulu ʻia ʻana i ke kino, nui ka hopena hypoglycemic i ka insulin. Hiki i ke hypoglycemia koʻikoʻi ke hoʻomohala me ka hoʻohana o ka waiʻona e ka mea maʻi me ka maʻi maʻi. Inā mālama ʻia ka paʻa o ka glucose i ke koko ma kahi kiʻekiʻe loa, kahi ʻano maʻi o ka ketoacidosis maʻi. Hiki ke ulu ʻia kahi hoʻopiʻi koʻikoʻi inā loaʻa ka mea maʻi i kahi haʻahaʻa haʻahaʻa o ka insulin ma mua o ka mea e pono ai. Hiki ke hana ʻia kēia ma ke ʻano nui o ka pono o ka insulin i ka manawa o ka maʻi, he kuhi hewa ʻole o ka meaʻai, ke ʻina o ka pae ʻana o ka insulin a i ʻole ka lawa o ka nui o ka insulin. Hiki ke hoʻomohala ʻia ka hoʻomohala ʻana o ka ketoacidosis ma ka nānā ʻana i ka urine, kahi kuhi ka nui o ke kō a me ke kino o ka ketone. Hōʻike iki, maʻamau i loko o kekahi mau hola a i ʻole mau lā paha, nā hōʻailona e like me ka makewai, nui ka diuresis, nāi momona, ke ʻōpū, ka ʻōpala maloʻo, hohonu a wikiwiki hoʻi ka hanu. Inā ʻaʻole i mālama ʻia ka mea maʻi ma kēia ʻano, he mea hiki nō ke ola i ka coma maʻi maʻi me kahi hopena momona.

ʻO nā ʻōlelo kūikawā no ka hoʻohana ʻana i ka lāʻau ʻo Farmasulin

I ka papa o ka 4-8 IU, 1-2 mau manawa i ka lā, hiki ke hoʻohana ʻia nā lāʻau lapaʻau e like me ka anabolic agent no ka hoʻohemo nui ʻana o ke kino, furunculosis, thyrotoxicosis, atony o ka ʻōpū, hepatitis maʻi, a me nā ʻano mua o ka cirrhosis. Ma ka hoʻomaʻamaʻa psychiatric, ua kuhikuhi ʻia no ka hoʻoikaika ikaika ʻana i ka lāʻau. Hoʻohana ʻia no ka mālama ʻana i ka coma maʻi maʻi, ma ka hoʻomaʻamaʻa ʻana.

Hoʻolaha nā lāʻau lapaʻau Pharmaculin

ʻO Glucagon, diazoxide, derivia phenothiazine, diuretics thiazide, corticosteroids, hormon tiroid, contraceptives hormonal waha e hoʻonāwaliwali i ka hopena hypoglycemic o ka insulin. ʻO ka hoʻonui pinepine ʻia o ka hopena o ka hopena hypoglycemic a me ka hoʻokūkū pū ʻana o nā salicylates, guanethidine, inhibitor MAO, oxytetracycline, a me nā steroid anabolic. Hoʻonui ka Insulin i ka hopena anti-tuberculosis o PASK. ʻO ka insulin a me ka strophanthin ka hopena ʻē aʻe i ka hana kontrakile a me ka metabolism myocardial, ma muli o ke ʻano o ka nāwaliwali ʻana a i ʻole ka hōʻino ʻia paha o kā lākou hopena. I ka hoʻomaʻamaʻa ʻana me ka insulin, ma mua o ka hoʻokele ʻana o ka anaprilin e hoʻolōʻihi i ka hypoglycemia lōʻihi. Hoʻonui ka lāʻauʻona i ka hopena o ka hypoglycemia.

ʻO ka overdose Pharmasulin, nā hōʻailona a me ka mālama

He kūlike loa a pili. E kumu ana i ka hopena hypoglycemic nui. ʻAno i kaʻai ʻona (ka hapa ʻole o ka ʻai ʻana i ka meaʻai ma hope o ka inikua insulin), ka hana kino kino a me ka waiʻona i mea e ola ʻia ai. Hoʻomaʻamaʻa pinepine ia hiki ke loaʻa me kahi papa labile o ka maʻi, i nā poʻe maʻi me nā maʻi maʻi, me ka hana o ka renal impaired. Hōʻike ʻia ka maʻi e ka hōʻuluʻulu, haʻalulu a me nā ʻano hopena autonomʻo, wikiwiki wikiwiki loa. Hoʻokomo ʻia ka hoʻomaʻamaʻa i ka manawa o ka hoʻokomo o ka glucose i loko (i ka hoʻomaka mua o ka hypoglycemia). I mea e pale ai i ka hypoglycemia, hāʻawi ʻia ka mea maʻi i kahi kīʻī a i ʻole nā cubes wai. Inā makemake ia, ʻo ka hoʻōla ʻia ʻana o ka huina o 40% ka hopena o ka glucose wai i loko o intravenously a i ʻole 1 mg o ka glucagon e mālama ʻia i ka intramuscularly. Inā ʻaʻole hōʻemi ka mea maʻi mai ka coma ma hope o ka hoʻohālikelike ʻana i ke kōpaʻa koko, pono ia e hoʻokele mannitol a i ʻole ka nui o nā corticosteroids e pale ai i ka edema cerebral.

Ke mālama nei i nā kūlana o ka lāʻau Farmasulin

Ma kahi wahi pouli i kahi mahana o 2-8 ° С. ʻAʻole pono ke ʻōleʻa a hoʻolaha ʻia paha i ka lā! Hiki ke mālama i ka vial i hoʻohana ʻia i ka wa wela (a hiki i 25 ° C) no 6 mau pule. I ka hihia o ka honu a i ʻole ka nānā ʻana o kahi kala o ka supernatant ma hope o ka hoʻopaʻa ʻana i nā ʻike o ke kō, ʻaʻole pono kēia lāʻau lapaʻau.

ʻAoa:

Kahuiki (Farmasulin)

Hoʻolaha 1 ml i ka hopena ʻo Farmasulin N:
ʻO ka insulin biosynthetic kanaka (i hana ʻia e ka ʻenehana recombinant DNA) - 100 IU,
Nā mea lako hou.

1 ml o Pharmasulin H NP ka hoʻokuʻuia ʻana me ka:
ʻO ka insulin biosynthetic kanaka (i hana ʻia e ka ʻenehana recombinant DNA) - 100 IU,
Nā mea lako hou.

1 ml o ke kaʻa ʻana o Farmasulin H 30/70 ka mea:
ʻO ka insulin biosynthetic kanaka (i hana ʻia e ka ʻenehana recombinant DNA) - 100 IU,
Nā mea lako hou.

Ka hana lāʻau lapaʻau

ʻO ka Farmasulin ka lāʻau lapaʻau me ka hopena hypoglycemic i haʻi ʻia. ʻO ka Farmasulin ka insulin, he mea e hoʻoponopono ai i ka metabolism glucose. No ka hoʻohui ʻana i ka hana metabolism glucose, hoʻopilikia ka insulin i ka nui o nā kaʻina anabolic a me nā anti-catabolic i loko o nā kiko. Hoʻonui ka insulin i ka synthesis o ka glycogen, glycerol, nā mea palaka a me nā momona momona i loko o nā ʻiʻo, a me ka hoʻonui ʻana aʻe i ka komo ʻana o nā waikawa amino a hōʻemi iho i ka glycogenolysis, ketogenesis, neoglucogenesis, lipolysis a me catabolism o nā protein a me nā waikawa amino.
ʻO Farmasulin N kahi mea hana wikiwiki e hana i ka insulin. Aia i ka insulin kanaka i loaʻa e ka ʻenehana DNA ʻenehana. Hoʻomaopopo ka hopena therapeutic 30 mau minuke ma hope o ka hoʻokele subcutaneous a lōʻihi i nā hola 5-7. Loaʻa ka ʻike plasma plasma i loko o 1-3 mau hola ma hope o ke kaha inake.

Ke hoʻohana nei i ka lāʻau lapaʻau Hizasulin H NP, ke kaʻi o ka plasma pae ikaika e nānā ʻia ma hope o 2-8 mau hola. Hoʻopuka ka hopena therapeutic i loko o 60 mau minuke ma hope o ka hoʻokele ʻana a lōʻihi i nā hola 18-24.
Ke hoʻohana nei i ka lāʻau ʻo Farmasulin N 30/70, e hoʻomohala ka hopena therapeutic i loko o 30-60 mau minuke a kū i nā hola 14-15, i kekahi mau mea maʻi a hiki i 24 hola. ʻO ka ʻike plasma plasma kiʻekiʻe e ʻike ʻia ai nā 1-8.5 mau hola ma hope o ka hoʻokele ʻana.

Ke ʻano o ka noi

Kukuiulin N:
Kuhi ʻia ka lāʻau lapaʻau no ka hoʻokele subcutaneous a me ka intravenous. Eia kekahi, hiki ke hoʻokau ʻia i ka hopena i ka intramuscularly, ʻoiai ʻoi aku ka maikaʻi o ka hoʻokele subcutaneous a me ka intravenous. ʻO ka hopena a me ka papa hana o ka lawelawe ʻana i ka lāʻau ʻo Farmasulin N e hoʻoholo ʻia e ke kauka, i ka noʻonoʻo ʻana i nā pono o kēlā me kēia maʻi. ʻO ka subcutaneously, ʻoi aku ka lāʻau e mālama ai i ka ʻāʻī, ka ʻūhā, ka ʻūhā a me nā ʻōpū. Ma ka wahi like, pono ke kauoha ʻia kahi maʻi hou aku ma mua o ka 1 manawa i kēlā me kēia mahina. Ke hoʻoluhi nei, e pale i ka loaʻa ʻana o ka hopena i loko o ke ana vascular. Mai ʻōpala i kahi kahua wili.

Hoʻoholo ʻia ka hoʻonāʻau ʻana i nā pahu maʻi no ka hoʻohana ʻana me kahi penikala syringe i hōʻailona ʻia ʻo "CE". Hoʻohana ʻia ia e hoʻohana i kahi hālea a i ʻole ka aniani maikaʻi ʻole i loaʻa nā māhele like ʻole. Inā pono e hoʻokō i nā hoʻomākaukau ʻana i nā insulin, pono e hana ʻia me nā ʻāpana syringe ʻokoʻa. E pili ana i ke ala o ka hoʻopiʻi ʻana i ke kāleka, e like me ke kānāwai, ua hāʻawi ʻia ka ʻike i nā ʻōlelo ʻōlelo no ka peni ʻo syringe.

Me ka hoʻolauna ʻana o ka hopena i nā kīʻaha, pono nā ʻano ʻoka, nā puka e like me kēia ʻano o ka insulin. Manaʻo ʻia e hana i nā syringes o ka hui like a me ke ʻano e lawelawe ai i ka hopena Pharmasulin N, no ka mea e hoʻohana ai nā syringes ʻē aʻe e alakaʻi i ka hewa kūpono ʻole. ʻAe wale nō ke kala ʻoluʻolu, ʻaʻole ana i nā kala ʻole i ʻike i nā ʻāpana ʻike ʻia. Pono e kiʻi ʻia kēia maʻi ma lalo o nā kūlana aseptic. Hoʻomaopopo ʻia e hoʻolauna i kahi hopena o ka mahana o ka lumi. No ke kiʻi ʻana i ka hopena i loko o ka ʻāwili, pono ʻoe e huki mua i ka ʻāwili i ka hōʻailona e pili ana i ka nui o ka inika no ka insulin, e hoʻokomo i ka pūlohelohe i loko o ka wai vial a koko. Ma hope o kēlā, ua hoʻohuli i ka pahu a hoʻākoakoa ʻia ka nui o ka hoʻonā. Inā pono e lawelawe i nā insulins ʻē aʻe, hoʻohana ʻia kahi syringe ʻokoʻa a me ka pono no kēlā me kēia.

Farmasulin H NP a me Farmasulin H 30/70:
ʻO Farmasulin H 30/70 - kahi pūnaehana i hoʻomākaukau ʻia i nā hanana ʻo Farmasulin N a me Farmasulin H NP, kahi e hiki ai iā ʻoe ke hoʻokomo i nā insulins e like ʻole me ka hoʻomākaukau ʻana i ka hoʻomākaukau ʻana o ka hui ʻana o ka insulin.

ʻO Farmasulin H NP a me Farmasulin H 30/70 e lawelawe ʻia e ka ʻākala ma hope o nā rula aseptic. Hana ʻia ka inikia subcutaneous i loko o ka poʻohiwi, pōpoki, ʻūhā a me nā ʻōpū paha hoʻi, pono hoʻi e noʻonoʻo ʻia i ka pūnaewele manawa ʻoi aku ka hana ʻoi aku ma mua o ka manawa o ka malama. Hōʻalo i ka hoʻopili ʻana me ka hoʻonā ʻana i ka wā maʻi. Hoʻohana ʻia ia e hoʻohana i loko o ka hoʻonā i kahi o ka hūʻū ʻole ʻana i nā mea i ʻole a i ʻole nā huki ʻole i loaʻa ma ka paia o ke kō. Ma mua o ka hoʻokele ʻana, e lūlū i ka ʻaka i nā palma o kou mau lima a hiki i kahi hoʻokūkū kūlike i hoʻokumu ʻia. Hoʻole ʻia ka lūlū ʻana i ka pīpī, no ka mea hiki i kēia ke alakaʻi i ke ʻano o ka pahuhū a me nā pilikia me ka hoʻonohonoho o ka maʻi pololei. E hoʻohana wale i nā syringes me kahi puka hoʻohālikelike kūpono no ka nui o ka insulin. ʻO ka palena ma waena o ka mālamaʻana i ka lāʻau a me ka hoʻokomo o ka meaʻai, ʻaʻole pono ma mua o 45-60 mau mau minuke no ka lāʻau Farmasulin H NP a ʻoi aku nō ma mua o 30 mau minuke no ka lāʻau Farmasulin H 30/70.

I ka wā o ka hoʻohana ʻana i ka lāʻau ʻo Farmasulin, pono e ʻai ʻia kekahi meaʻai.
I mea e hoʻoholo ai i ka pālepa, ʻike ʻia ka nui o ka glycemia a me glucosuria i ka lā a me ka pae o ka wikiwiki o ka glycemia wikiwiki.
I ke kau ʻana i ka pīhoihoi, pono ʻoe e huki mua i ka ʻāwili i ka hōʻailona e hoʻoholo ai i ke ʻano koi, a laila hoʻokomo i ka pūpū i loko o ka vial a i hoʻoheheʻe ʻia. A laila, hoʻohuli i ka ʻili i luna a hōʻiliʻili i ka nui o ka ʻaina e koi ai.

Pono ke lawelawe ʻana i ka Pharmasulin ma o ka paʻa ʻana i ka ʻili ma waena o nā manamana lima a hoʻokomo i ka lāʻau kuʻi ma ke kihi o 45 degere. I mea e pale ai i ka kahe o ka insulin ma hope o ka hoʻokele ʻana o ka ʻaina, e hoʻohaʻahaʻa iki ʻia ka pūnaewele injection. Lā ʻia ka ʻānai ʻia i ke kahua o ka inikini insulin.
ʻO kahi mea hou, me ka loaʻa o ke kūmole, hōʻailona a me nā ʻano o ka insulin, pono ke nānā i ke kauka.

Nā hopena hopena

I loko o ka wā o ka lapaʻau me ka Pharmasulin, ka hopena pinepine ʻole e like me ka hypoglycemia, hiki ke loaʻa i ka nalowale o ka ʻike a me ka make. ʻO ka pinepine loa, ʻo ka hypoglycemia ka hopena o ka ʻai ʻana i ka ʻai, ka hoʻokau ʻana i ka wai kiʻekiʻe o ka insulin a i ʻole ka make nui, a me ka inu wai ʻoluʻolu. I mea i hōʻemi ʻia ai ka hoʻomohala ʻana o ka hypoglycemia, pono e mālama ʻia nā mea i ʻōlelo ʻia a e hoʻokele pono ʻia ka lāʻau lapaʻau e like me nā ʻōlelo a ke kauka.

Eia kekahi, ʻo ka mea nui me ka hoʻohana mau ʻana i ka lāʻau ʻo Farmasulin, ka hoʻomohala ʻana o ka pale ʻana i ka insulin a me ka atrophy a i ʻole hypertrophy o ke kōpala momona subcutaneous ma ka pūnaewele injection hiki. Hiki nō hoʻi i ka hoʻomohala ʻana o ka hopena o ka hypersensitivity, me nā mea hoʻopalike mea i ke ʻano o ka hypotension arterial, bronchospasm, luhiluhi ka nui a me ka urticaria.
Me ka hoʻomohala ʻana o nā hopena i makemake ʻole ʻia, pono ʻoe e kamaʻilio i ke kauka, e like me kekahi o lākou e koi ai i ka hoʻokuʻu ʻana o ka lāʻau lapaʻau a me ka lāʻau kūikawā.

Nā Hoʻohui

ʻAʻole i kuhikuhi ʻia ʻo Farmasulin i nā poʻe maʻi me kahi hypersensitivity i ʻike ʻia i nā mea o ka lāʻau.
Pāpā ʻia ka Farmasulin no ka hoʻohana ʻana me ka hypoglycemia.
ʻO nā mea maʻi me ka maʻi lōʻihi, maʻi neuropathy maʻi, a me nā mea maʻi e loaʻa ana i nā beta-blockers, pono e hoʻohana i ka lāʻau lapaʻau ʻo Pharmasulin me ka makaʻala, ʻo ia mau ʻano i nā hōʻailona o ka hypoglycemia e maʻalahi a loli paha.

Pono ʻoe e kamaʻilio aku me kāu kauka e pili ana i ka make o ka lāʻau lapaʻau ma ka hihia o ka hoʻomohala ʻana i ka adrenal, kidney, pituitary a me thyroid gland dysfunctions, ʻo ia hoʻi ma nā ʻano aʻeha o nā maʻi, e like me kēia hihia, e koi ʻia ka hoʻoponopono ʻana o ka insulin.
Ma ka hoʻomaʻamaʻa pediatric, no nā kumu olakino, ua ʻae ʻia e hoʻohana i ka lāʻau lapaʻau ʻo Pharmasulin mai ka wā o ka hānau ʻana.
Pono e mālama pono i ka wā e hoʻokele ai i nā mīkini palekana me ka mālama ʻana i kahi kaʻa i ka wā o ka hopena me ka ʻoihana ʻo Pharmasulin.

Kahawai

Hiki ke hoʻohana ʻia ʻo Farmasulin i nā wahine hāpai, akā naʻe, pono e noʻonoʻo ʻia i ka wā hāpai, pono ke nānā ʻia i ka nānā ʻana i ke ʻano o ka nui o ka insulin, no ka mea ʻo kēia manawa ke hoʻololi nei ka pono o ka insulin. Ke kauoha ʻia nei ʻoe e nīnau aku i kāu kauka inā ua loaʻa i ka hoʻolālā a i ka hoʻolālā ʻana paha i ka wā hāpai. ʻO ka glucose ka wā e hāpai ana i ka wā hāpai e mālama pono ʻia.

Hoʻohui nūhou

Hiki ke hōʻemi ʻia ka hopena o ka lāʻau ʻo Farmasulin i ka wā i hui pū ʻia me nā ʻōpū ʻūpuna, ka lāʻau thyroid, glucocorticosteroids, beta2-adrenergic agonists, heparin, hoʻomākaukau lithium, diuretics, hydantoin, a me nā lāʻau antiepileptic.

Aia ka emi ʻana o ke koi i ka insulin me ka hoʻohana pū ʻana me ka lāʻau hoʻohui ʻo Pharmasulin me nā ʻāpana antidiabetic oral, salicylates, monoamine oxidase inhibitor, sulfonamide inhibitors, angiotensin-converting enzyme inhibitors, beta-adrenergic receptor blockers, ethyl alkohol, octreotide, tetraflamide, tetrafiloferfam, tetrofrefa, tetrofrefref, tetrofrefer a phenylbutazone.

Hoʻopili me nā lāʻau lapaʻau a me nā ʻano ʻē aʻe ʻē aʻe

Hoʻokomo kekahi mau lāʻau i ka metabolism glucose. Pono e hōʻike ʻia ke kauka i kekahi mea e pili ana i ka mālama ʻana i hāʻawi ʻia i ka insulin o ke kanaka.

Inā pono ʻoe e hoʻohana i nā lāʻau lapaʻau ʻē aʻe, pono ʻoe e ʻōlelo me kāu kauka.

Hiki ke hoʻonui ʻia ka pono o ka insulin me ka hoʻohana ʻana i nā lāʻau lapaʻau me ka hana hyperglycemic, e like me ka contraceptives waha, glucocorticoids, hormone thyroid a me ka ulu ulu ʻana, danazole, β ₂ kinolomimia (e.g. ritodrin, salbutamol, terbutaline), thiazides.

Hiki ke emi i ka insulin me ka hoʻohana ʻana i nā lāʻau lapaʻau me ka hana hypoglycemic, e like me ka lālau hypoglycemic oral, salicylates ((no ka acetylsalicylic acid), sulfaantibiotics, kekahi antidepressants (MAO inhibitors), kekahi angiotensin-inhibiting enzyme inhibitors (blockptenaprilpropyl, Captaprilopril II, Captaprilopril II, Captaprilopril II) ʻaʻole koho-ʻokoʻa a i ʻole inu wai.

Hiki i nā Somatostatin analogues (octreotide, lanreotide) ke hoʻoikaika a hoʻonāwaliwali i ka pono o ka insulin.

Nā hiʻohiʻona noi

Pono e hoʻokaʻawale i nā ʻano a i ʻole paha o ka insulin i lalo o ka mākaʻikaʻi koʻikoʻi. ʻO ka hoʻololi ʻana i ka ʻike, brand (mea hana), ʻano (wikiwiki, waʻa, hana lōʻihi), ʻano (manu manu, insulin insulin kanaka, mea hou o ka insulin kanaka) a me / a i ʻole ka hoʻomākaukau ʻana o ka insulin (i loaʻa i ka ʻenehana recombinant DNA, i loko o ʻaʻole e like me nā holoholona holoholona) e koi i ka loli ʻana.

ʻO ka hewa ma ke mālama ʻana i nā maʻi me ka insulin kanaka e ʻokoʻa i ka dosage e hoʻohana ʻia ana i ka mālamaʻana i ka insulin o ka hoʻomaka ʻana o nā holoholona. Inā loaʻa he ʻano no ka hoʻoponopono ʻana iā ia, hiki ke hoʻokō ʻia ia ʻano hoʻololi mai ka hopena mua a i ʻole ma mua o nā hebedoma mua a i ʻole mau mahina paha.

Ma kekahi mau mea maʻi i loaʻa i ka hopena hypoglycemic ma hope o ka hoʻokaʻa ʻana iā lākou mai ka hoʻoponopono o ka hoʻokele ʻana o ka insulin o ka holoholona i hele mai i ka hoʻoponopono regimen o ka lawelawe ʻana i ka insulin o ke kanaka, ua ʻōlelo iki a ʻano ʻole paha nā hōʻailona mua o ka hypoglycemia e like me nā hōʻailona i ʻike ʻia ma mua o kēia mau mea maʻi i ka wā e mālama ʻia me ka manu holoholona. I ka poʻe maʻi me ka holomua nui o nā papa glucose koko (no ka laʻana, no ka hoʻonui ʻana i ka insulin insulin), kekahi i ʻole a i ʻole kekahi o nā ʻōpuhi o mua o ka hypoglycemia e ʻike ʻia i ka wā e hiki mai ana, e ʻike ʻia lākou. Loko ʻē aʻe paha nā ʻōmole mua o ka maʻi hypoglycemia a i ʻole ka haʻi ʻia i nā mea maʻi me ka lōʻihi lōʻihi o ka maʻi maʻi a me ka neuropathy diabetes, a i nā mea maʻi e lawe nei i nā lāʻau lapaʻau ʻē aʻe, e like me β-blockers, i like me ka hana i hoʻohana ʻia.

ʻO ka hypoglycemia a i ʻole hyperglycemic reaksi ʻaʻole i hoʻoponopono ʻia, hiki ke alakaʻi i ka ʻike, koma, a i ʻole ka make.

Hiki i ke kaulike maikaʻi a i ʻole ka hoʻokuʻuʻana i ka mālamaʻana (ʻoi aku paha no nā poʻe maʻi me ka maʻi kūpaʻa i ka insulin) hiki ke alakaʻi i ka hyperglycemia a me ka nui o ka maʻi ketoacidosis maʻi.

Hiki ke hānai ʻia nā antibi i loko o ka mālama ʻana i ka inika manuahi kanaka, ʻoiai me nā mea haʻahaʻa haʻahaʻa ma mua o ka mea manu i hoʻomaʻemaʻe ʻia.

Ka pono o ka insulin e loli nui me ka hana adrenal i hoʻopōmaikaʻi ʻia, nā aniani pituitary, nā pāpale thyroid, nā pūpū a i ʻole a me ka palaka ʻole.

Hiki ke hoʻonui i ka insulin i ka wā o nā maʻi a i lalo paha o ka hopena o ke kaumaha o ka naʻau.

Hiki ke kūpono ka hoʻoponopono ʻana i nā maʻi inā loaʻa nā loli i ka nui o ka hoʻoikaika kino a i ʻole kaʻai maʻamau.

Hoʻohui ʻia me ka pioglitazone

Ua hōʻike ʻia nā pilikia o ka puʻuwai puʻuwai me ka hoʻohana pū ʻana o ka pioglitazone me ka insulin, aemaise i nā poʻe maʻi e loaʻa i nā hopena pōpilikia o ka puʻuwai puʻuwai.

Hoʻohana i ka wā hāpai a lactation.

ʻO ka mālama ʻana i ke kaʻe o ka nui o ke kaila koko i nā wahine hāpai he mea koʻikoʻi nui lākou inā he mālama ʻia lākou me ka insulin (me ka ʻano pono o ka insulin a me ka hopena e pili ana i ka hopena o ka maʻi maʻi). Ka pono o ka insulin e hoʻemi i ka wā o ka trimester mua o ka hapai, ma hope o ka hoʻonui i ka wā o ka trimesters lua a me ke kolu. ʻO nā wahine me nā maʻi maʻi e hoʻomaopopo i kā lākou mau kauka i ka wā hāpai a i ʻole ka makemake e hānai.

ʻO ka nānā nui ʻana i ka glucose koko a me ke olakino holoʻokoʻa nui loa no nā wahine hāpai i ka maʻi maʻi.

I nā wahine me ka maʻi maʻi, i ka wā o ka hōʻuluʻulu ʻana, pono e pono ai e hoʻoponopono i nā inikua insulin a me / a i ʻole eʻai ai.

ʻO ka hiki ke alakaʻi i ka hopena i ka wā e lawe ana i nā kaʻa a i ʻole nā hana ʻē aʻe.

Hiki i ka hypoglycemia ke hoʻopilikia i ka luhi o ka nānā a me ka hoʻonāukiuki, ʻo ia hoʻi, he hōʻaʻi koʻikoʻi ia i nā kūlana e koi ana i nā mea i hōʻike ʻia, no ka hoʻohālikelike ʻana i ke kaʻa a lawelawe paha i nā polokalamu mīkini.

Pono e ʻike ʻia nā mea maʻi e pili ana i nā hana mua e pono ai e mālama i mua o ka hoʻokele ʻana e pale ai i ka exacerbations o ka hypoglycemia, inā paha inā ʻike mua ʻole nā hōʻailona hōʻailona o ka hypoglycemia a i ʻole he kiko ʻole, a i ʻole hanana exacerbations o hypoglycemia pinepine. I kēia mau kūlana, mai hoʻokuke.

Nā hopena maikaʻiʻole

ʻO ka hypoglycemia kahi hopena maʻamau o ka inika insulin i nā mea maʻi me ka maʻi maʻi. Hiki i ka hypoglycemia koʻikoʻi ke alakaʻi i ka nalowale o ka ʻike, ma kekahi mau hihia koʻikoʻi - a make. ʻAʻole hāʻawi ʻia nā ʻikepili e pili ana i ka pinepine o hypoglycemia, no ka mea e pili ana ka hypoglycemia me ka nui o ka insulin a me nā mea ʻē aʻe, e like me ke ʻano o ka mea maʻi a me ka pae o ka hana kino.

Hiki ke ʻike ʻia nā hōʻike kūloko i nā loli e ke ʻano o nā wahi i hōʻola ʻia, ʻulaʻula ka ʻili o ka ʻili, ka huehue, ka ʻeha. Loko lākou ma hope o kekahi mau lā i kekahi mau pule. I kekahi mau hihia, ua pili ia ʻaʻole me ka insulin, akā me nā kumu ʻē aʻe, no ka laʻana, ka mea hoʻonāukiuki i ka hoʻohui o nā mea hoʻomaʻemaʻe kino ʻole a i ʻole o ka ʻike me nā inikua.

Allergy allergy is a great side effects is a formally generalised allergy to insulin, including a rash on the whole surface of the body, shortness of breath, wheezing, nurunake koko, hoʻohaʻahaʻa i ka naʻau, a me ka hoʻonui nui ʻana. ʻO nā hihia koʻikoʻi o nā maʻi āpau i hoʻoweliweli. I loko o nā hihia kūʻokoʻa loa o nā maʻi kūlike i ka Farmasulin ® N NP, pono e hana koke i nā hana kūpono. Pono ia e hoʻololi i ka insulin a i ʻole ka desensitizing therapy.

ʻO ka pinepine, hiki i ka lipodystrophy i ke kahua o ka maʻi ʻaina.

Ua hōʻike ʻia nā pilikia o ka edema me ka hoʻohana ʻana i ka lāʻau o ka insulin, i loko o nā hihia me ka hoʻohaʻahaʻa ʻana i ka hana metabolism, ua hoʻomaikaʻi ʻia e ka maʻi insulin intensive.

Ka hoʻonohonoho ʻana a me ke ʻano o ka hoʻokuʻu ʻana

FARMASULIN® H NP

hāpene. d / in. 100 IU / ml fl. 10 ml, ʻAʻoleʻae 1
hāpene. d / in. 100 IU / ml kalepona 3 ml, Āa 5

Human Humanulin 100 IU / ml
Nā kumuwaiwai ʻē aʻe: distilled m-cresol, glycerol, fenol, protamine sulfate, zinc oxide, sodium phosphate dibasic, hydrochloric acid 10% solution a me ka sodium hydroxide 10% solution (a hiki i ka pH 6.9-7.5), ka wai no ka huikau ana.
Kuhi i ka 1 ml o Farmasulin N NP kahi 100 IU o ka manuola biosynthetic kanaka i hana ʻia me ka ʻenehana recombinant DNA.

FARMASULIN® H 30/70

hāpene. d / in. 100 IU / ml fl. 10 ml, ʻAʻoleʻae 1
hāpene. d / in. 100 IU / ml kalepona 3 ml, Āa 5

Human Humanulin 100 IU / ml
Nā kumuwaiwai ʻē aʻe: distished m-cresol, glycerol, fenol, protamine sulfate, zinc oxide, sodium phosphate dibasic, hydrochloric acid 10% solution a me sodium hydroxide 10% solution (a hiki i ka pH 6.9-7.5), ka wai no ka huikau ana.
1 ml o Farmasulin H 30/70 he 100 IU o ka biosynthetic insulin o ke kanaka i hoʻohana me ka ʻenehana recombinant DNA.

Lapaʻau lāʻau

Farmasulin N - ʻO ka hana hana wikiwiki, kahi hoʻomākaukau no ka insulin o ke kanaka i loaʻa e ka ʻenehana loea DNA.
ʻAʻoleʻike nā pharmacokinetics o ka insulin i ka hana metabolic o ka hormone.
ʻO ka hoʻomaka ʻana o ka hopena he 30 mau minuke ma hope o ka mālama subutanutan. ʻO ka pae kiʻekiʻe e ʻike ʻia ma waena o 1 a me 3 mau hola ma hope o ka loaʻa ʻana. ʻO ka lōʻihi o ka mālamaʻana i ka mālama therapeutic mai 5 a 7 mau hola. Hoʻololi ka hana o ka insulin ma muli o ka nui o kona nui, ke kōpaʻa, ka wahi paʻa, a me ke ʻano kino o ka mea maʻi.
I ka wā o nā noiʻi toxicological, ʻaʻohe hopena koʻikoʻi e pili ana i ka hoʻohana ʻia ʻana o ka lāʻau lapaʻau.